Sign In
Buy TRAW
$1.45
+0.0300 (+2.11%)
At Close: Jun 03, 2026
Traws Pharma Earnings Calls
Mar 31, 2026
(Upcoming)
| Release date | Aug 13, 2026 |
| EPS estimate | -$1.20 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 24.74% |
Dec 31, 2025
-$0.710 (41.98%)
| Release date | Apr 15, 2026 |
| EPS estimate | -$1.22 |
| EPS actual | -$0.710 |
| EPS Surprise | 41.98% |
| Revenue estimate | 60K |
| Revenue actual | - |
Nov 24, 2025
$95.66 (1,101.68%)
| Release date | Mar 31, 2025 |
| EPS estimate | -$9.55 |
| EPS actual | $95.66 |
| EPS Surprise | 1,101.68% |
| Revenue estimate | 60K |
| Revenue actual | 56K |
| Revenue Surprise | -6.67% |
Sep 30, 2025
| Release date | Nov 13, 2025 |
| EPS estimate | - |
| EPS actual | -$449.26 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Traws Pharma
Below you can see how TRAW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2025
| Release date | Nov 13, 2025 |
| Price on release | $1.77 |
| EPS estimate | - |
| EPS actual | -$449.26 |
| Date | Price |
|---|---|
| Nov 07, 2025 | $1.95 |
| Nov 10, 2025 | $1.94 |
| Nov 11, 2025 | $1.89 |
| Nov 12, 2025 | $2.14 |
| Nov 13, 2025 | $1.77 |
| Nov 14, 2025 | $2.17 |
| Nov 17, 2025 | $2.08 |
| Nov 18, 2025 | $2.13 |
| Nov 19, 2025 | $2.11 |
| 4 days before | -9.23% |
| 4 days after | 19.21% |
| On release day | 22.60% |
| Change in period | 8.21% |
Nov 24, 2025
Beat
| Release date | Mar 31, 2025 |
| Price on release | $2.30 |
| EPS estimate | -$9.55 |
| EPS actual | $95.66 |
| EPS surprise | 1,101.68% |
| Date | Price |
|---|---|
| Mar 25, 2025 | $2.65 |
| Mar 26, 2025 | $2.53 |
| Mar 27, 2025 | $2.57 |
| Mar 28, 2025 | $2.40 |
| Mar 31, 2025 | $2.30 |
| Apr 01, 2025 | $2.14 |
| Apr 02, 2025 | $2.32 |
| Apr 03, 2025 | $2.18 |
| Apr 04, 2025 | $1.96 |
| 4 days before | -13.21% |
| 4 days after | -14.78% |
| On release day | -6.96% |
| Change in period | -26.04% |
Dec 31, 2025
Beat
| Release date | Apr 15, 2026 |
| Price on release | $1.23 |
| EPS estimate | -$1.22 |
| EPS actual | -$0.710 |
| EPS surprise | 41.98% |
| Date | Price |
|---|---|
| Apr 09, 2026 | $1.50 |
| Apr 10, 2026 | $1.48 |
| Apr 13, 2026 | $1.61 |
| Apr 14, 2026 | $1.59 |
| Apr 15, 2026 | $1.23 |
| Apr 16, 2026 | $1.21 |
| Apr 17, 2026 | $1.25 |
| Apr 20, 2026 | $1.39 |
| Apr 21, 2026 | $1.28 |
| 4 days before | -18.00% |
| 4 days after | 4.07% |
| On release day | -1.63% |
| Change in period | -14.67% |
Mar 31, 2026
(Upcoming)
| Release date | Aug 13, 2026 |
| Price on release | - |
| EPS estimate | -$1.20 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 28, 2026 | $1.52 |
| May 29, 2026 | $1.46 |
| Jun 01, 2026 | $1.47 |
| Jun 02, 2026 | $1.42 |
| Jun 03, 2026 | $1.45 |
Traws Pharma Earnings History
Earnings Calendar
FAQ
When is the earnings report for TRAW?
Traws Pharma, Inc. (TRAW) has scheduled its earnings report for Aug 13, 2026 after the markets close.
What is the TRAW price-to-earnings (P/E) ratio?
TRAW P/E ratio as of Jun 03, 2026 (TTM) is -1.06.
What is the TRAW EPS forecast?
The forecasted EPS (Earnings Per Share) for Traws Pharma, Inc. (TRAW) for the first fiscal quarter 2026 is -$1.20.
What are Traws Pharma, Inc.'s retained earnings?
On its balance sheet, Traws Pharma, Inc. reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
